AstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s development of an AI tool for detecting hypophosphatasia (HPP). Through the ...
Pangaea Data, a company focused on detecting patients with hard-to-diagnose diseases, is collaborating with pharma giant AstraZeneca to scale AI that helps identify and connect patients to clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results